Neuropeptide Y (NPY) — Protein
Introduction Neuropeptide Y (NPY) is a 36-amino acid peptide neurotransmitter and hormone that plays diverse roles in the central and peripheral nervous systems. It is one of the most abundant neuropeptides in the mammalian brain and is critically involved in stress response, appetite regulation, energy homeostasis, and circadian rhythms. Emerging evidence links NPY signaling to neuroprotection and modulation of neurodegenerative processes in Alzheimer's Disease (AD), Parkinson's Disease (PD), and related conditions [1][2].
...
Neuropeptide Y (NPY) — Protein
Introduction Neuropeptide Y (NPY) is a 36-amino acid peptide neurotransmitter and hormone that plays diverse roles in the central and peripheral nervous systems. It is one of the most abundant neuropeptides in the mammalian brain and is critically involved in stress response, appetite regulation, energy homeostasis, and circadian rhythms. Emerging evidence links NPY signaling to neuroprotection and modulation of neurodegenerative processes in Alzheimer's Disease (AD), Parkinson's Disease (PD), and related conditions [1][2].
<div class="infobox infobox-protein"> <table> <tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Neuropeptide Y (NPY)</th></tr> <tr><td><strong>Protein Name</strong></td><td>Neuropeptide Y</td></tr> <tr><td><strong>Gene</strong></td><td>[NPY](/genes/npy)</td></tr> <tr><td><strong>UniProt ID</strong></td><td>[P01308](https://www.uniprot.org/uniprot/P01308)</td></tr> <tr><td><strong>PDB Structures</strong></td><td>[1RON](https://www.rcsb.org/structure/1RON), [1QFA](https://www.rcsb.org/structure/1QFA)</td></tr> <tr><td><strong>Molecular Weight</strong></td><td>~10,271 Da (mature peptide)</td></tr> <tr><td><strong>Subcellular Localization</strong></td><td>Secreted peptide (dense-core vesicles)</td></tr> <tr><td><strong>Protein Family</strong></td><td>Neuropeptide Y family (PP-fold)</td></tr> <tr><td><strong>Brain Regions</strong></td><td>Hypothalamus, amygdala, [hippocampus](/brain-regions/hippocampus), [cortex](/brain-regions/cortex), striatum</td></tr> <tr> <td class="label">Associated Diseases</td> <td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/asthma" style="color:#ef9a9a">Asthma</a>, <a href="/wiki/cardiac" style="color:#ef9a9a">Cardiac</a></td> </tr> <tr> <td class="label">KG Connections</td> <td><a href="/atlas" style="color:#4fc3f7">78 edges</a></td> </tr> </table> </div>
Structure NPY is synthesized as a 97-amino acid precursor (pre-pro-NPY) that undergoes proteolytic processing:
Pre-pro-NPY (97 aa) : Signal peptide + NPY sequence
Pro-NPY (69 aa) : After signal peptide cleavage
Mature NPY (36 aa) : C-terminal amide, formed by peptidylglycine α-hydroxylating monooxygenase (PAM)
Structural Features
PP-fold motif : NPY shares the pancreatic polypeptide fold with peptide YY (PYY) and pancreatic polypeptide (PP)
N-terminal coil : Important for receptor binding specificity
C-terminal tail : Essential for receptor activation
Amidation : C-terminal Tyr36 is amidated, crucial for biological activity
Normal Function
Neurophysiological Roles NPY is expressed in various brain regions and performs multiple functions:
Stress response : Modulates hypothalamic-pituitary-adrenal (HPA) axis activity
Appetite regulation : Orexigenic (appetite-stimulating) effects via Y1 and Y5 receptors
Energy homeostasis : Regulates energy balance and metabolism
Circadian rhythms : Shows circadian secretion patterns
Memory and learning : Influences hippocampal synaptic plasticity
Anxiety and mood : Anxiolytic effects in the amygdala
Seizure control : Endogenous anticonvulsant
Receptor Signaling NPY acts through five G protein-coupled receptors (GPCRs):
| Receptor | Distribution | Primary Effects | |----------|-------------|-----------------| | Y1R (NPY1R) | Brain, periphery | Anxiolysis, appetite, vasoconstriction | | Y2R (NPY2R) | Brain (presynaptic) | Inhibits neurotransmitter release | | Y4R (NPY4R) | Peripheral tissues | Energy homeostasis | | Y5R (NPY5R) | Hypothalamus | Appetite regulation | | Y6R (NPY6R) | Limited (pseudogene in humans) | N/A |
Role in Alzheimer's Disease NPY alterations are implicated in AD pathophysiology:
Changes in AD Brain
NPY levels : Variable reports—some studies show increased NPY in AD brains, others show decreased
Y1R expression : Reduced Y1R binding in AD hippocampus
Y2R alterations : Changes in Y2R in AD cortex
Neuroprotective Mechanisms
Anti-excitotoxic effects : NPY protects against glutamate-induced neurotoxicity via Y2R
Anti-amyloid effects : NPY may reduce [amyloid-beta](/proteins/amyloid-beta) (Aβ) toxicity
Memory enhancement : Y1R and Y5R activation improves memory consolidation
Neurogenesis : NPY promotes hippocampal neurogenesis
Therapeutic Implications
NPY receptor agonists as cognitive enhancers
Y1R/Y5R-targeted AD therapeutics
Gene therapy approaches using NPY overexpression
Role in Parkinson's Disease NPY interactions in PD include:
Dopaminergic system : NPY modulates dopaminergic neuron survival
Motor control : NPY in basal ganglia influences movement
Levodopa-induced dyskinesia : Y1R antagonism may reduce dyskinesias
Neuroinflammation : NPY exerts anti-inflammatory effects in microglial models
Role in Other Neurodegenerative Diseases
Huntington's Disease
NPY interneurons are relatively spared in HD
NPY overexpression may provide neuroprotection
Y2R agonists under investigation
Epilepsy
NPY is a potent endogenous anticonvulsant
NPY gene therapy in clinical trials for epilepsy
Seizures upregulate NPY expression
Stroke and Ischemia
NPY is neuroprotective in cerebral ischemia
Y1R and Y5R mediate ischemic preconditioning
Therapeutic Potential
Drug Development | Target | Approach | Status | |--------|----------|--------| | Y1R agonists | Cognitive enhancement | Preclinical | | Y2R agonists | Anti-excitotoxic | Preclinical | | Y5R antagonists | Appetite suppression | Clinical (obesity) | | NPY gene therapy | Epilepsy treatment | Phase I/II trials |
Challenges
[Blood-brain barrier](/entities/blood-brain-barrier) penetration
Receptor subtype selectivity
Balancing anxiogenic vs anxiolytic effects
Dose-dependent effects
Key Publications
[Cerda-Reverter JM, et al. Neuropeptide Y gene and receptors: evolutionary aspects. Prog Brain Res. 2011](https://doi.org/10.1016/j.yfrne.2011.05.002)
[Colmers WF, Bleakman D. Effects of neuropeptide Y on neuronal excitability. Neuropeptides. 2004](https://pubmed.ncbi.nlm.nih.gov/15567467/)
[Sørensen G, et al. NPY and neuroprotection. Prog Neuropsychopharmacol Biol Psychiatry. 2021](https://pubmed.ncbi.nlm.nih.gov/33242789/)
[Redrobe JP, et al. NPY Y1 receptors in Alzheimer's disease. J Neurochem. 2002](https://pubmed.ncbi.nlm.nih.gov/11954098/)
[Grove KL, et al. NPY in the developing brain. J Comp Neurol. 2001](https://pubmed.ncbi.nlm.nih.gov/11172044/)
See Also
[NPY Gene](/genes/npy)
[NPY1R Gene](/genes/npy1r)
[NPY2R Gene](/genes/npy2r)
[NPY5R Gene](/genes/npy5r)
[Neuropeptide Signaling](/mechanisms/neuropeptide-signaling)
[Hypothalamic NPY Neurons](/cell-types/hypothalamic-npy-neurons)
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)
[Huntington's Disease](/diseases/huntingtons)
References
[Unknown, Sørensen G, Wortwein G, Dencker M, Woldbye DP. Neuropeptide Y in neurodegeneration: friend or foe? Prog Neuropsychopharmacol Biol Psychiatry. 2021;104:110037 (2021)](https://pubmed.ncbi.nlm.nih.gov/33242789/)
[Unknown, Redrobe JP, Dumont Y, St-Pierre JA, Quirion R. Multiple receptors for neuropeptide Y in the hippocampus: anatomical and functional implications. J Neurochem. 2002;82(4):834-847 (2002)](https://pubmed.ncbi.nlm.nih.gov/11954098/)
[Unknown, Cerda-Reverter JM, Larhammar D. Neuropeptide Y family of peptides: structure, anatomical expression, evolution and function. Prog Brain Res. 2011;187:1-16 (2011)](https://doi.org/10.1016/j.yfrne.2011.05.002)
[Unknown, Colmers WF, Bleakman D. Effects of neuropeptide Y on the electrical properties of neurons. Trends Neurosci. 2004;27(9):541-547 (2004)](https://pubmed.ncbi.nlm.nih.gov/15567467/)
Show full description